At this time, there is no generic version of dexmethylphenidate extended-release because the drug is protected by a patent. The patent expires in 2015, at which time a generic dexmethylphenidate extended-release can be manufactured and sold. Do not buy any of the fake, substandard, and potentially dangerous drugs currently sold as "generic dexmethylphenidate extended-release."
Generic Dexmethylphenidate Extended-Release: An Overview
Dexmethylphenidate extended-release (
Focalin XR®) is a prescription medication that has been licensed to treat attention deficit hyperactivity disorder (
ADHD). Although
dexmethylphenidate extended-release is a stimulant, it has effects that are the opposite of what would be expected of a stimulant. While stimulants like caffeine can cause hyperactivity, dexmethylphenidate extended-release has a calming effect.
Dexmethylphenidate extended-release is manufactured by Novartis Pharmaceuticals. The medicine is currently protected by a patent that prevents any generic version of it from being manufactured. Yet, if you search the Internet for "
generic dexmethylphenidate extended-release," you may find a number of companies selling it. The fact is that these medicines are fake, substandard, and potentially dangerous. You should not buy any generic dexmethylphenidate extended-release until there is an approved generic available.
When Will There Be a Generic Dexmethylphenidate Extended-Release?
The first patent for dexmethylphenidate extended-release currently expires in 2015. This is the earliest date that a generic version of dexmethylphenidate extended-release could become available. However, there are other circumstances that could come up to extend the exclusivity period of dexmethylphenidate extended-release beyond 2015. These circumstances could include things such as other patents for specific dexmethylphenidate extended-release uses or lawsuits. Once dexmethylphenidate extended-release goes off patent, there may be several companies that manufacture a generic dexmethylphenidate extended-release drug.